CD4 and neoplasm: Strikingly, the anti-tumor effects mediated by doxycycline treatment were absent in immunocompromised nu/nu mice harboring CT26 tumors (Figure 7E) and in mice treated with depleting antibodies against CD8 and CD4, implying an essential contribution from the adaptive immune system to this anti-tumor response (Figure 7F).